FDA Head: Indonesia to compete in global drug testing

After Australia’s Recce Pharmaceuticals begins Phase 3 clinical trial for its diabetic foot infection treatment in Indonesia, Professor Taruna Ikrar, Chairperson of Indonesia's Food and Drug Authority (BPOM), comments on Indonesia's clinical trial ambitions, and adds that the country is in talks with South Korea’s Daewon Pharm and India’s Dr. Reddy's Laboratories for similar initiatives.